Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy in Bladder Cancer: Ready for Prime Time?
Author:
Affiliation:
1. Hôpital Saint-Louis, Université Paris-Diderot, Paris, France
2. University Hospital, Rouen, France
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Reference8 articles.
1. Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
2. Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
3. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder
4. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer;Urologic Oncology;2022
2. Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer;Bladder Cancer;2018
3. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy;International Urology and Nephrology;2017-07-03
4. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons;Nature Reviews Clinical Oncology;2016-11-22
5. C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation;Journal of Translational Medicine;2016-02-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3